Some researchers have attempted to treat MS with the use of IFN-γ for 18 patients, but 7 of them had exacerbation of the disease and, in addition, found an increase in the proliferation of peripheral blood leukocytes and an increase in activated NK cells [29]. The gene discussed is IFNG; the disease is myeloid sarcoma.